The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessment of clinical activity of E7080, a multitargeted kinase inhibitor, in patients with advanced melanoma treated in two phase I trials.
D. S. Hong
Research Funding - Eisai
D. S. Boss
No relevant relationships to disclose
H. Glen
Research Funding - Eisai
J. Mink
Employment or Leadership Position - Eisai
M. Ren
Employment or Leadership Position - Eisai
C. Andresen
Employment or Leadership Position - Eisai
J. P. O'Brien
Employment or Leadership Position - Eisai
R. Kurzrock
No relevant relationships to disclose
J. H. M. Schellens
No relevant relationships to disclose
J. J. Nemunaitis
No relevant relationships to disclose
T. R. J. Evans
Research Funding - Eisai